By the end of 2019, the companies intend to complete the transfer of technologies and to launch full-cycle production of innovative thrombolytic medicines at Petrovax Pharm’s production facility in the Moscow Region.

Members of the Supervisory Council are appointed for a five-year term. The Council is responsible for the design and implementation of the university’s development strategy, and general oversight over its activities.

Vladimir Potanin, the owner and founder of Interros Group, one of the largest private investment companies in Russia, has completed acquisition of a controlling stake in Petrovax Pharm. For more details please visit www.petrovax.com